Paper32031335
Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2.
Li Y and 3 others. Thorac Cancer, 2020. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2. Papers, record 32031335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32031335
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| HMGA2 Protein | Major topic |
| Hypoglycemic Agents | Major topic |
| Metformin | Major topic |
| Sp1 Transcription Factor | Major topic |
| Apoptosis | |
| Cell Proliferation | |
| Female | |
| Humans | |
| Tumor Cells, Cultured |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2018SCZ030 | Department of Finance of Jilin Province | International | PubMed | |
| 20180101136JC | Department of Science and Technology of Jilin Province | International | PubMed | |
| YXZN-201803 | Excellent Talents Training Plan China-Japan Union Hospital of Jilin University | International | PubMed | |
| 20160414047GH | International cooperation projects of Jilin Province | International | PubMed | |
| 20190304047YY | Medical and Health Project of Jilin Province | International | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18403645 | Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. | Mol Cancer Res | 2008 | https://conductscience.org/library/papers/18403645 | PubMed |
| 2 | 24511112 | Repurposing to fight cancer: the metformin-prostate cancer connection. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/24511112 | PubMed |
| 3 | 19465398 | HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/19465398 | PubMed |
| 4 | 21388661 | Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. | Gynecol Oncol | 2011 | https://conductscience.org/library/papers/21388661 | PubMed |
| 5 | 15358530 | Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. | FEBS Lett | 2004 | https://conductscience.org/library/papers/15358530 | PubMed |
| 6 | 21252160 | Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21252160 | PubMed |
| 7 | 28271076 | Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. | J Diabetes Res | 2017 | https://conductscience.org/library/papers/28271076 | PubMed |
| 8 | 25024815 | Growth inhibition of colon cancer cells by compounds affecting AMPK activity. | World J Gastrointest Oncol | 2014 | https://conductscience.org/library/papers/25024815 | PubMed |
| 9 | 25218351 | HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. | Cancer Lett | 2014 | https://conductscience.org/library/papers/25218351 | PubMed |
| 10 | 24858012 | Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24858012 | PubMed |
| 11 | 24096736 | Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. | Mol Cell Biochem | 2014 | https://conductscience.org/library/papers/24096736 | PubMed |
| 12 | 15834550 | Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). | Diabetologia | 2005 | https://conductscience.org/library/papers/15834550 | PubMed |
| 13 | 31337349 | Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. | BMC Cancer | 2019 | https://conductscience.org/library/papers/31337349 | PubMed |
| 14 | 20007691 | Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20007691 | PubMed |
| 15 | 19138981 | The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. | Cancer Prev Res (Phila) | 2008 | https://conductscience.org/library/papers/19138981 | PubMed |
| 16 | 17721431 | Modelling breast cancer: one size does not fit all. | Nat Rev Cancer | 2007 | https://conductscience.org/library/papers/17721431 | PubMed |
| 17 | 18832382 | HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18832382 | PubMed |
| 18 | 25347702 | Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy. | BMC Biol | 2014 | https://conductscience.org/library/papers/25347702 | PubMed |
| 19 | 14645522 | Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14645522 | PubMed |
| 20 | 29063073 | The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis. | Chronic Dis Transl Med | 2017 | https://conductscience.org/library/papers/29063073 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40518465 | High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors. | Virchows Arch | 2025 | https://conductscience.org/library/papers/40518465 | PubMed |
| 33315504 | The pro-migration and anti-apoptosis effects of HMGA2 in HUVECs stimulated by hypoxia. | Cell Cycle | 2020 | https://conductscience.org/library/papers/33315504 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32031335
GET https://conductscience.org/api/papers/v1/32031335/references?page=2